이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Home-Based Corrective Exercise With Remote Reinforcement for Upper Crossed Syndrome

2026년 11월 4일 업데이트: JORGE MONTERO CÁMARA, Cardenal Herrera University

Effects of a Home-Based Corrective Exercise Program With Active Remote Reinforcement on Craniovertebral Angle, Rounded Shoulder Posture, Thoracic Kyphosis, Pain, Cervical and Shoulder Disability, and Pulmonary Function i Adults With Upper Crossed Syndrome: A Two-Arm Parallel Randomized Controlled Trial

Upper Crossed Syndrome (UCS) is a musculoskeletal condition defined by simultaneous forward head posture (craniovertebral angle, CVA < 52°), rounded shoulders (RSP > 52°), and thoracic hyperkyphosis (> 42°). It is highly prevalent in sedentary workers and musicians and is associated with neck pain, shoulder pain, and reduced pulmonary function. This two-arm parallel randomized controlled trial will compare two home-based corrective exercise programs over 12 weeks in adults with confirmed UCS. Both groups (Experimental, EG; Control, CG) perform the same 20-minute program three times per week: diaphragmatic breathing re-education and targeted muscle strengthening and stretching. The EG additionally uses a volumetric incentive spirometer (Coach2, 4000 mL) as respiratory biofeedback and receives active remote reinforcement (biweekly video calls + asynchronous educational material from a physiotherapist); the CG performs the same exercises without the spirometer and receives only minimal adherence monitoring. Outcomes are assessed at baseline (week 0) and at weeks 4, 8, and 12. Primary outcome: craniovertebral angle (CVA) measured by lateral photogrammetry. Secondary outcomes: rounded shoulder angle (RSP), thoracic kyphosis (bubble inclinometer and smartphone inclinometer), pain (Visual Analogue Scale), cervical disability (Neck Disability Index), shoulder pain and disability (SPADI), exercise adherence, and pulmonary function (spirometry: FVC, FEV₁/FVC, MVV) at weeks 0 and 12. Recruitment will take place at the Associació Amics de la Música de Meliana, Fisioterapia A Punto, and Universidad Cardenal Herrera CEU (Valencia, Spain). A total of 96 participants (48 per arm) will be enrolled over a 2-year recruitment window.

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

연구 유형

중재적

등록 (추정된)

96

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • • Confirmed UCS diagnosis, defined by the simultaneous presence of: (a) craniovertebral angle (CVA) < 52°; (b) rounded shoulder posture angle (RSP) > 52°; and (c) thoracic kyphosis angle > 42°.

    • Age between 18 and 65 years.
    • Available and willing to perform the home exercise program and to attend all four face-to-face assessment sessions (weeks 0, 4, 8, and 12).
    • Access to a camera-equipped device (smartphone or tablet) for remote monitoring and reinforcement.
    • Ability to understand the study procedures and to sign informed consent.

Exclusion Criteria:

  • Severe cervical or thoracic pathology: vertebral fracture, neoplasm, infection, or active systemic inflammatory disease.

    • Spinal surgery within the preceding 12 months.
    • Respiratory pathology contraindicating use of a volumetric incentive spirometer: recent pneumothorax (< 6 weeks), COPD GOLD grade III-IV, or unstable bronchial asthma.
    • Active physiotherapy treatment specifically targeting UCS within the preceding 3 months.
    • Pregnancy or breastfeeding.
    • Cognitive impairment or language barrier preventing comprehension of the exercise program.
    • Simultaneous participation in another clinical trial.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Experimental Group (EC)

Home-based corrective exercise program (3 sessions/week × 12 weeks, 20 min/session) combining: (1) diaphragmatic breathing re-education with a volumetric incentive spirometer (Coach2, 4000 mL, Smiths Medical) as biofeedback - 4 progressive levels, 10 repetitions; (2) muscle strengthening and stretching targeting the deep cervical flexors, lower and middle trapezius, rhomboids, and pectoral/suboccipital muscles. The EG additionally receives active remote reinforcement: a biweekly video call with a physiotherapist and asynchronous educational material (written guides and video tutorials) delivered via a messaging platform.

Home-based corrective exercise program (3 sessions/week × 12 weeks, 20 min/session) combining: (1) diaphragmatic breathing re-education with a volumetric incentive spirometer (Coach2, 4000 mL, Smiths Medical) as biofeedback - 4 progressive levels, 10 repetitions; (2) muscle strengthening and stretching targeting the deep cervical flexors, lower and middle trapezius, rhomboids, and pectoral/suboccipital muscles. The EG additionally receives active remote reinforcement: a biweekly video call with a physiotherapist and asynchronous educational material (written guides and video tutorials) delivered via a messaging platform.

활성 비교기: Control Group (CG)

Identical home-based corrective exercise program (3 sessions/week × 12 weeks, 20 min/session) with the same muscle strengthening and stretching exercises. The CG does not use an incentive spirometer (diaphragmatic breathing performed without device) and does not receive active remote reinforcement; adherence monitoring is minimal (standardized paper diary).

Identical home-based corrective exercise program (3 sessions/week × 12 weeks, 20 min/session) with the same muscle strengthening and stretching exercises. The CG does not use an incentive spirometer (diaphragmatic breathing performed without device) and does not receive active remote reinforcement; adherence monitoring is minimal (standardized paper diary).

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Craniovertebral Angle (CVA)
기간: Baseline (Week 0), Week 4, Week 8, Week 12

Angle formed between the horizontal line at the C7 spinous process and the line connecting C7 to the ipsilateral ear tragus, measured by lateral photogrammetry using standardized adhesive markers and Kinovea software. A lower CVA indicates greater forward head posture (normal > 52°).

Baseline (Week 0), Week 4, Week 8, Week 12

2차 결과 측정

결과 측정
측정값 설명
기간
Rounded Shoulder Posture Angle (RSP)
기간: Baseline (Week 0), Week 4, Week 8, Week 12

Angle between the line connecting the C7 spinous process to the right acromion and the horizontal, measured by lateral photogrammetry (Kinovea). Values > 52° indicate rounded shoulder posture.

Baseline (Week 0), Week 4, Week 8, Week 12
Thoracic Kyphosis Angle - Bubble Inclinometer
기간: Baseline (Week 0), Week 4, Week 8, Week 12

Single-inclinometer sequential method: the instrument (Baseline, Fabrication Enterprises Inc., White Plains, NY) is zeroed at T1 and the angle is read at T12. Three measurements per time point; mean used for analysis.

Baseline (Week 0), Week 4, Week 8, Week 12
Thoracic Kyphosis Angle - Smartphone Inclinometer
기간: Baseline (Week 0), Week 4, Week 8, Week 12

Same T1-T12 sequential method using the Clinometer app (Plaincode) on iPhone 17. The upper corner of the narrow side of the phone is placed at T1 (zeroed to 0°), then moved to T12 (angle read). Three measurements per time point; mean used for analysis.

Baseline (Week 0), Week 4, Week 8, Week 12
Pain Intensity - Visual Analogue Scale (VAS)
기간: Baseline (Week 0), Week 4, Week 8, Week 12

100-mm horizontal VAS (0 = no pain; 100 = worst imaginable pain) for neck and interscapular pain during the past week. Minimum clinically important difference (MCID): 15 mm.

Baseline (Week 0), Week 4, Week 8, Week 12
Cervical Disability - Neck Disability Index (NDI)
기간: Baseline (Week 0), Week 4, Week 8, Week 12

10-item self-reported questionnaire assessing the impact of neck pain on daily activities; total score 0-50. Spanish validated version used. MCID: 5 points (10%). Interpretation: 0-8% no disability; 10-28% mild; 30-48% moderate; 50-64% severe; ≥ 64% complete disability.

Baseline (Week 0), Week 4, Week 8, Week 12
Shoulder Pain and Disability - SPADI
기간: Baseline (Week 0), Week 4, Week 8, Week 12

13-item self-reported questionnaire with two subscales (Pain: 5 items; Disability: 8 items), each item scored 0-10. Total score 0-100 (higher = worse). MCID: 13-18 points. Spanish validated version used.

Baseline (Week 0), Week 4, Week 8, Week 12
Exercise Adherence
기간: Weeks 1-12 (cumulative at each assessment point)

Percentage of prescribed sessions completed out of 36 planned sessions (3/week × 12 weeks), recorded in standardized session diaries. Adequate adherence defined as ≥ 70%

Weeks 1-12 (cumulative at each assessment point)
Forced Vital Capacity (FVC, % predicted)
기간: Baseline (Week 0), Week 12

Spirometric measurement (forced vital capacity as percentage of age-sex-height-weight predicted value). ATS acceptability and reproducibility criteria applied; 3 measurements per session, mean used.

Baseline (Week 0), Week 12
FEV₁/FVC Ratio (% predicted)
기간: Baseline (Week 0), Week 12

Ratio of forced expiratory volume in 1 second to forced vital capacity, expressed as percentage of predicted value.

Baseline (Week 0), Week 12
Maximum Voluntary Ventilation (MVV, % predicted)
기간: Baseline (Week 0), Week 12

Spirometric measure of maximum airflow over 12-15 seconds, expressed as percentage of predicted value.

Baseline (Week 0), Week 12

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

일반 간행물

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 9일

기본 완료 (추정된)

2028년 11월 9일

연구 완료 (추정된)

2028년 12월 31일

연구 등록 날짜

최초 제출

2026년 10월 29일

QC 기준을 충족하는 최초 제출

2026년 11월 4일

처음 게시됨 (실제)

2026년 11월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 4일

마지막으로 확인됨

2026년 10월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • CEEI26_865
  • CEEI26_865 (기타 식별자: CardenalHU)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .